Pediatric HIV formulation (bioequivalence study)

· Elim Pediatric Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pediatric HIV formulation (bioequivalence study), covering 2011-11-10 to 2011-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Pediatric Formulations to Treat HIV Infection [Phase 1]